---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-086284"
form_type: "8-K"
ticker: "JANX"
cik: "0001817713"
company_name: "Janux Therapeutics, Inc."
filed_at: "2025-06-13T23:59:59+00:00"
generated_at: "2026-05-19T08:56:14.936462+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Janux Therapeutics shareholders elect three Class I directors, ratify EY

## Summary
- David Campbell, Ron Barrett, and Winston Kung elected Class I directors with >42M votes each.
- Ernst & Young ratified as auditor for FY2025: 56.15M for, 27K against.
- Advisory vote on executive compensation approved: 53.2M for, 1.15M against.
- Advisory vote favors 1-year frequency for future say-on-pay votes: 54.0M for 1 year.
- 59.2M shares outstanding, 56.2M present at meeting; broker non-votes of 1.87M.

## SEC filing metadata
- accession: 0000950170-25-086284
- form_type: 8-K
- ticker: JANX
- cik: 0001817713
- company_name: Janux Therapeutics, Inc.
- filed_at: 2025-06-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1817713/000095017025086284/0000950170-25-086284-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1817713/000095017025086284/janx-20250611.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-086284
- JSON: https://secwatch.observer/filing/0000950170-25-086284.json
- Plain text: https://secwatch.observer/filing/0000950170-25-086284.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.